Last deal

$1.33M
Local Amount - CHF 1.3M

Amount

Seed

Stage

04.10.2022

Date

2

all rounds

$3.74M

Total amount

date founded

Financing round

General

About Company
PreComb develops technologies to optimize cancer therapies for difficult-to-treat cases.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2018

Number of employees

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

PreCombTherapeutics AG is a Swiss biotech company specializing in in vitro cancer diagnostics. Their automated microtumor-based 3DTwin™ technology allows hospitals to integrate the testing process on-site. By evaluating multiple cancer drugs, combinations, and concentrations directly on patient-derived micro-tumors, the test maximizes treatment outcomes. This innovative approach helps physicians choose effective therapies for cancer treatment, improving the chances of success and enhancing patients' quality of life.
Similar Companies
1000
SageMedic

SageMedic

SageMedic develops a genome-free SAGE Direct Platform that increases clinical success rates for drugs in development.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Redwood City, CA, USA

total rounds

4
AcuraStem

AcuraStem

AcuraStem is a startup company that uses advanced technology to create patient-specific treatments for neurodegenerative diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Monrovia, CA, USA

total rounds

5

total raised

$16M
KIYATEC

KIYATEC

KIYATEC creates functional 3D models of tumors using patients' own living cells to test cancer therapies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Greenville, SC, USA

total rounds

12

total raised

$30.95M
Notable Labs

Notable Labs

Notable Labs offers personalized drug combination testing for cancer patients.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Medical

Location

Foster City, CA, USA

total rounds

12

total raised

$54.84M

count Of Investments

1

Financials

Funding Rounds
2
2

Number of Funding Rounds

$3.74M

Money Raised

Their latest funding was raised on 04.10.2022. Their latest investor LongeVC. Their latest round Seed

Date 
Funding Round 
Investors 
Money Raised 
Lead 
04.10.2022
2
$1.33M
Local Amount - CHF 1.3M
27.04.2021
3
$2.41M
Local Amount - CHF 2.2M
Kinled Holding

Kinled Holding

Kinled is a venture capital firm that invests in start-ups and growth companies with patented technology.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

New York, NY, USA

count Of Investments

85

count Of Exists

7
LongeVC

LongeVC

LongeVC is an early-stage venture firm that invests in biotechnology and healthcare.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Venture Capital, Biotechnology, Financial Services

Location

Lugano, Switzerland

count Of Investments

12

count Of Exists

1
Kinled Holding

Kinled Holding

Kinled is a venture capital firm that invests in start-ups and growth companies with patented technology.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

New York, NY, USA

count Of Investments

85

count Of Exists

7
Co-Investors
Investors
4
2

Number of lead investors

4

Number of investors

LongeVC

LongeVC

LongeVC is an early-stage venture firm that invests in biotechnology and healthcare.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Venture Capital, Biotechnology, Financial Services

Location

Lugano, Switzerland

count Of Investments

12

count Of Exists

1
Sergey Jakimov

Sergey Jakimov

current job

Longevity Science Foundation
Longevity Science Foundation

organization founded

2
High-Tech Grunderfonds

High-Tech Grunderfonds

High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven start-ups.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Bonn, Germany

count Of Investments

838

count Of Exists

107
Anke Cassing

Anke Cassing

current job

High-Tech Grunderfonds
High-Tech Grunderfonds
Kinled Holding

Kinled Holding

Kinled is a venture capital firm that invests in start-ups and growth companies with patented technology.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

New York, NY, USA

count Of Investments

85

count Of Exists

7
Patrick Fisher

Patrick Fisher

Mr. Fisher founded Creation Investments in 2007, leading the firm in Emerging Markets, Private Equity and Impact Investing since inception. He is responsible for overall management of the firm, specifically deal generation, due diligence, deal structuring, and negotiation, along with fundraising and investor relations. Mr. Fisher also has portfolio management responsibility along with Mr. Vander Weele, and is currently a director for many Creation portfolio companies. He is a market leader in EM and Impact Investing, leading investments or providing advisory services on equity and debt transactions in businesses which serve the Bottom of the Economic Pyramid (BOP) through microfinance / financial services, health care, affordable housing, clean energy, and technology. Prior to founding Creation Investments, Mr. Fisher spent the majority of his career working in the financial services industry, most recently for JPMorgan Chase. His work experience includes years of service in International Banking and Global Treasury and Trade Services, primarily covering Asia and Latin America. Mr. Fisher lived in China, specifically in Hong Kong and Beijing. Prior to that, Mr. Fisher marketed interest rate, commodity foreign exchange derivatives on Bank One’s Chicago trading floor. He received his credit underwriting training from American National Bank in Chicago. He has started numerous businesses, established three previous investment funds and has served on the board of several for-profit and not-for-profit organizations. His past experience includes executive leadership for a not-for-profit organization in Chicago. Mr. Fisher is a graduate of the Kellogg School of Management at Northwestern University, where he received a Master of Business Administration degree in Finance and Marketing. He also received his Bachelor of Arts, magna cum laude, at the University of Notre Dame, where he majored in Philosophy, Theology, and Computer Applications. Mr. Fisher has studied biblical Greek, speaks basic Mandarin and advanced Spanish. He is a Certified Cash Manager, Certified Treasury Professional and a member of Mensa. He currently lives in Chicago, Illinois, with his wife Jenny Nicole, son Desmond, daughter Meara and dog Bacon.

current job

Creation Investments Capital Management, LLC
Creation Investments Capital Management, LLC

People

Founders
2
Jens Kelm
Jens Kelm

Jens Kelm

Jens Kelm is the Co-Founder at PreComb Therapeutics AG. Jens Kelm attended ETH Zurich.

current job

PreComb Therapeutics AG
PreComb Therapeutics AG

organization founded

2

Jens Kelm

Peter Steiner
Peter Steiner

Peter Steiner

Formerly, Executive Director and Head of the Production & Processes department of ESBATech, a Novartis company. Responsible for manufacturing process development of BEOVU® (Brolucizumab, Novartis) and other drug candidates successfully tested in clinical POC trials. Co-founder and former member of the board of Insilico Biotechnology AG. Peter holds a PhD in Biotechnology from the ETH Zürich.

current job

PreComb Therapeutics AG
PreComb Therapeutics AG

organization founded

1

Peter Steiner

Employee Profiles
3
Olivier Mauti

Olivier Mauti

CTO

Jens Kelm

Jens Kelm

Co-Founder & CEO

Peter Steiner

Peter Steiner

Co-founder, COO and president

Activity

Recent News
0